These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2148229)

  • 1. L-asparaginase treatment reduces the anticoagulant potential of the protein C system without affecting vitamin K-dependent carboxylation.
    Vigano'D'Angelo S; Gugliotta L; Mattioli Belmonte M; Cascione ML; Pattarini E; D'Angelo A
    Thromb Res; 1990 Sep; 59(6):985-94. PubMed ID: 2148229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein S and protein C anticoagulant activity in acute and chronic cardiac ischemic syndromes. Relationship to inflammation, complement activation and in vivo thrombin activity.
    D'Angelo A; Gerosa S; D'Angelo SV; Mailhac A; Colombo A; Agazzi A; Mazzola G; Chierchia S
    Thromb Res; 1994 Jul; 75(2):133-42. PubMed ID: 7974387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of L-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitors.
    Bezeaud A; Drouet L; Leverger G; Griffin JH; Guillin MC
    J Pediatr; 1986 May; 108(5 Pt 1):698-701. PubMed ID: 2939229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
    Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
    Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercoagulability during L-asparaginase treatment: the effect of antithrombin III supplementation in vivo.
    Gugliotta L; D'Angelo A; Mattioli Belmonte M; Viganò-D'Angelo S; Colombo G; Catani L; Gianni L; Lauria F; Tura S
    Br J Haematol; 1990 Apr; 74(4):465-70. PubMed ID: 2189489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between interleukin-6 and the natural anticoagulant system in acute stroke.
    Vila N; Reverter JC; Yagüe J; Chamorro A
    J Interferon Cytokine Res; 2000 Mar; 20(3):325-9. PubMed ID: 10762081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia.
    Dong X; Shi J; Zhou J; Chen X; Jin Y; Zhang X; Li X; Dai H; Wang J
    Thromb Res; 2013 Nov; 132(5):614-20. PubMed ID: 24074703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus, and under oral anticoagulant therapy.
    Takahashi H; Tatewaki W; Wada K; Shibata A
    Clin Chim Acta; 1989 Jun; 182(2):195-208. PubMed ID: 2528431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase.
    Mattioli Belmonte M; Gugliotta L; Delvos U; Catani L; Vianelli N; Cascione ML; Belardinelli AR; Mottola L; Tura S
    Haematologica; 1991; 76(3):209-14. PubMed ID: 1743591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.
    Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):57-60. PubMed ID: 8039761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
    Undar L; Ertuğrul C; Altunbaş H; Akça S
    Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavior of protein S during long-term oral anticoagulant therapy.
    Takahashi H; Wada K; Hayashi S; Hanano M; Tatewaki W; Shibata A
    Thromb Res; 1988 Aug; 51(3):241-9. PubMed ID: 2972087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase.
    Oner AF; Gürgey A; Kirazli S; Okur H; Tunç B
    Leuk Lymphoma; 1999 Apr; 33(3-4):361-4. PubMed ID: 10221516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
    Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased protein S activity in sickle cell disease.
    Marfaing-Koka A; Boyer-Neumann C; Wolf M; Leroy-Matheron C; Cynober T; Tchernia G
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):425-30. PubMed ID: 8414963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of protein C and vitamin K-dependent coagulation factors in patients on long-term oral anticoagulant therapy.
    Takahashi H; Hanano M; Hayashi S; Arai Y; Yoshino N; Takakuwa E; Tatewaki W; Nagayama R; Takizawa S; Shibata A
    Tohoku J Exp Med; 1986 Aug; 149(4):351-7. PubMed ID: 3775760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hemodialysis on protein C, protein S, and antithrombin III levels.
    Lai KN; Yin JA; Yuen PM; Li PK
    Am J Kidney Dis; 1991 Jan; 17(1):38-42. PubMed ID: 1824735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unbalanced coagulation-fibrinolysis potential during L-asparaginase therapy in children with acute lymphoblastic leukaemia.
    Semeraro N; Montemurro P; Giordano P; Schettini F; Santoro N; De Mattia D; Giordano D; Conese M; Colucci M
    Thromb Haemost; 1990 Aug; 64(1):38-40. PubMed ID: 2274927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional properties of the sex-hormone-binding globulin (SHBG)-like domain of the anticoagulant protein S.
    Saposnik B; Borgel D; Aiach M; Gandrille S
    Eur J Biochem; 2003 Feb; 270(3):545-55. PubMed ID: 12542704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.